166 related articles for article (PubMed ID: 22920668)
1. Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis.
Bosch A; Bertran SP; Lu Y; Garcia A; Jones AM; Dawson MI; Farias EF
Breast Cancer Res; 2012 Aug; 14(4):R121. PubMed ID: 22920668
[TBL] [Abstract][Full Text] [Related]
2. The activation of RARα prevents surgery-induced cognitive impairments via the inhibition of neuroinflammation and the restoration of synaptic proteins in elderly mice.
Chen Y; Zhou Y; Cai J; Xu J; Hu C; Chen H; Hong Y; Pan N; Jiang Y; Zhou C; Wei H; Xu Z; Liu L; Wu X; Cui W
Int Immunopharmacol; 2024 Mar; 130():111772. PubMed ID: 38432148
[TBL] [Abstract][Full Text] [Related]
3. Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.
McKeown MR; Corces MR; Eaton ML; Fiore C; Lee E; Lopez JT; Chen MW; Smith D; Chan SM; Koenig JL; Austgen K; Guenther MG; Orlando DA; Lovén J; Fritz CC; Majeti R
Cancer Discov; 2017 Oct; 7(10):1136-1153. PubMed ID: 28729405
[TBL] [Abstract][Full Text] [Related]
4. HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs.
Zheng B; Han M; Shu YN; Li YJ; Miao SB; Zhang XH; Shi HJ; Zhang T; Wen JK
Cell Res; 2011 Oct; 21(10):1487-508. PubMed ID: 21383775
[TBL] [Abstract][Full Text] [Related]
5. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.
Kessler JD; Kahle KT; Sun T; Meerbrey KL; Schlabach MR; Schmitt EM; Skinner SO; Xu Q; Li MZ; Hartman ZC; Rao M; Yu P; Dominguez-Vidana R; Liang AC; Solimini NL; Bernardi RJ; Yu B; Hsu T; Golding I; Luo J; Osborne CK; Creighton CJ; Hilsenbeck SG; Schiff R; Shaw CA; Elledge SJ; Westbrook TF
Science; 2012 Jan; 335(6066):348-53. PubMed ID: 22157079
[TBL] [Abstract][Full Text] [Related]
6. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.
Ferguson RD; Novosyadlyy R; Fierz Y; Alikhani N; Sun H; Yakar S; Leroith D
Breast Cancer Res; 2012 Jan; 14(1):R8. PubMed ID: 22226054
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl-peptidase 9 regulates the dynamics of tumorigenesis and metastasis in breast cancer.
Heß L; Aliar K; Grünwald BT; Griffin R; Lozan A; Knöller M; Khokha R; Brummer T; Reinheckel T
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167133. PubMed ID: 38531482
[TBL] [Abstract][Full Text] [Related]
8. Integrative multi-omic sequencing reveals the MMTV-Myc mouse model mimics human breast cancer heterogeneity.
Broeker CD; Ortiz MMO; Murillo MS; Andrechek ER
Breast Cancer Res; 2023 Oct; 25(1):120. PubMed ID: 37805590
[TBL] [Abstract][Full Text] [Related]
9. A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment.
Wei CH; Huang L; Kreh B; Liu X; Tyutyunyk-Massey L; Kawakami M; Chen Z; Shi M; Kozlov S; Chan KC; Andresson T; Carrington M; Vuligonda V; Sanders ME; Horowitz A; Hwu P; Peng W; Dmitrovsky E; Liu X
Sci Rep; 2023 Sep; 13(1):14907. PubMed ID: 37689790
[TBL] [Abstract][Full Text] [Related]
10. RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signaling.
Tolg C; Milojevic M; Qi FW; Pavanel HA; Locke MEO; Ma J; Price M; Nelson AC; McCarthy JB; Hill KA; Turley EA
Breast Cancer Res; 2023 Jun; 25(1):74. PubMed ID: 37349798
[TBL] [Abstract][Full Text] [Related]
11. Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model.
Alikhani N; Ferguson RD; Novosyadlyy R; Gallagher EJ; Scheinman EJ; Yakar S; LeRoith D
Oncogene; 2013 Feb; 32(8):961-7. PubMed ID: 22469977
[TBL] [Abstract][Full Text] [Related]
12. A context-specific role for retinoblastoma protein-dependent negative growth control in suppressing mammary tumorigenesis.
Francis SM; Chakrabarti S; Dick FA
PLoS One; 2011 Feb; 6(2):e16434. PubMed ID: 21364977
[TBL] [Abstract][Full Text] [Related]
13. RARγ promotes the invasion and metastasis of thyroid carcinoma by activating the JAK1-STAT3-CD24/MMPs axis.
Zhang FX; Xu P; Zhang LJ; Fan R; Zhang HX; Liu DH; Liu K; Shen DY
Int Immunopharmacol; 2023 Dec; 125(Pt A):111129. PubMed ID: 37897947
[TBL] [Abstract][Full Text] [Related]
14. MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes.
Sullivan DK; Deutzmann A; Yarbrough J; Krishnan MS; Gouw AM; Bellovin DI; Adam SJ; Liefwalker DF; Dhanasekaran R; Felsher DW
Oncogene; 2022 Nov; 41(45):4960-4970. PubMed ID: 36207533
[TBL] [Abstract][Full Text] [Related]
15. Allosteric Regulation in the Ligand Binding Domain of Retinoic Acid Receptorγ.
Chebaro Y; Sirigu S; Amal I; Lutzing R; Stote RH; Rochette-Egly C; Rochel N; Dejaegere A
PLoS One; 2017; 12(1):e0171043. PubMed ID: 28125680
[TBL] [Abstract][Full Text] [Related]
16. Conditional Gene Targeting Reveals Cell Type-Specific Roles of the Lysosomal Protease Cathepsin L in Mammary Tumor Progression.
Parigiani MA; Ketscher A; Timme S; Bronsert P; Schlimpert M; Kammerer B; Jacquel A; Chaintreuil P; Reinheckel T
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707827
[No Abstract] [Full Text] [Related]
17. PAPAS promotes differentiation of mammary epithelial cells and suppresses breast carcinogenesis.
Ren S; Bai F; Schnell V; Stanko C; Ritsch M; Schenk T; Barth E; Marz M; Wang B; Pei XH; Bierhoff H
Cell Rep; 2024 Jan; 43(1):113644. PubMed ID: 38180837
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 catalytic activity has little effect on tumor formation and metastases in a mouse model of breast cancer.
Clark-Knowles KV; Dewar-Darch D; Jardine KE; McBurney MW
PLoS One; 2013; 8(11):e82106. PubMed ID: 24278473
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis.
Reaves DK; Hoadley KA; Fagan-Solis KD; Jima DD; Bereman M; Thorpe L; Hicks J; McDonald D; Troester MA; Perou CM; Fleming JM
Mol Cancer Res; 2017 Feb; 15(2):165-178. PubMed ID: 27856957
[TBL] [Abstract][Full Text] [Related]
20. The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer.
Reich LA; Moerland JA; Leal AS; Zhang D; Carapellucci S; Lockwood B; Jurutka PW; Marshall PA; Wagner CE; Liby KT
Sci Rep; 2022 Jan; 12(1):293. PubMed ID: 34997154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
